ArticleBlood2013

Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma.

P Leif Bergsagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.